Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice. 2009

Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
Division of Pharmaceutical Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kakumamachi, Kanazawa 920-1192, Japan.

Carnitine/organic cation transporter (OCTN) 2 (SLC22A5) plays a pivotal role in renal tubular reabsorption of carnitine, a vitamin-like compound, on apical membranes of proximal tubules, but its role in relation to therapeutic drugs remains to be clarified. The purpose of the present study was to elucidate the involvement of OCTN2 in renal disposition of a beta-lactam antibiotic, cephaloridine (CER), based on experiments with juvenile visceral steatosis (jvs) mice, which have a functional deficiency of the octn2 gene. Renal clearance of CER during constant intravenous infusion in wild-type mice was much higher than could be accounted for by glomerular filtration, but was decreased by increasing the infusion rate with minimal change in kidney-to-plasma concentration ratio, suggesting the existence of saturable transport mechanism(s) across the apical membranes. The plasma concentration profile and kidney-to-plasma concentration ratio after intravenous injection in jvs mice were higher than those in wild-type mice, whereas renal clearance in jvs mice was much lower than that in wild-type mice and could be accounted for by glomerular filtration. Uptake of CER by mouse OCTN2 was shown in Xenopus laevis oocytes expressing mouse OCTN2. The CER transport by OCTN2 exhibited saturation with K(m) of approximately 3 mM, which is similar to the renal CER concentration exhibiting saturation in renal clearance in vivo. The OCTN2-mediated CER transport was inhibited by carnitine and independent of Na(+) replacement in the medium. These results show OCTN2 on apical membranes of proximal tubules plays a major role in renal secretion of CER in mice.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D002509 Cephaloridine A cephalosporin antibiotic. Cefaloridine,Cephalomycine,Cephaloridin,Ceporin
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance

Related Publications

Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
June 2017, Drug metabolism and pharmacokinetics,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
December 2017, Drug metabolism and disposition: the biological fate of chemicals,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
June 2004, Drug metabolism and pharmacokinetics,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
September 2006, Molecular pharmacology,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
August 2018, Expert opinion on therapeutic targets,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
September 2015, Reproductive biology,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
January 2008, Drug metabolism and pharmacokinetics,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
February 2018, Scientific reports,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
September 2002, The Journal of pharmacology and experimental therapeutics,
Takashi Kano, and Yukio Kato, and Kimihiro Ito, and Takuo Ogihara, and Yoshiyuki Kubo, and Akira Tsuji
March 1999, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!